- $3.38tn
- $3.42tn
- $383.29bn
- 99
- 12
- 91
- 75
2019 September 28th | 2020 September 26th | 2021 September 25th | 2022 September 24th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 260,174 | 274,515 | 365,817 | 394,328 | 383,285 |
Cost of Revenue | |||||
Gross Profit | 98,392 | 104,956 | 152,836 | 170,782 | 169,148 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 196,244 | 208,227 | 256,868 | 274,891 | 268,984 |
Operating Profit | 63,930 | 66,288 | 108,949 | 119,437 | 114,301 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 65,737 | 67,091 | 109,207 | 119,103 | 113,736 |
Provision for Income Taxes | |||||
Net Income After Taxes | 55,256 | 57,411 | 94,680 | 99,803 | 96,995 |
Net Income Before Extraordinary Items | |||||
Net Income | 55,256 | 57,411 | 94,680 | 99,803 | 96,995 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 55,256 | 57,411 | 94,680 | 99,803 | 96,995 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.97 | 3.28 | 5.61 | 6.11 | 6.13 |
Dividends per Share |